A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.


Updates from The Motley Fool

Latest updates on VIVUS from Fool.com.


Stock Performance

VVUS vs. S&P 500 | 2 Year Performance
View Interactive VVUS Charts
Sponsored by

Key Data Points

Primary metrics and data points about VIVUS.
Current Price: $1.05
Prev Close: $1.09
Open: $1.08
Bid: $1.02
Ask: $1.11
Day's Range: $1.05 - $1.09
52wk Range: $0.92 - $2.25
Volume: 110,815
Avg Vol 382,004
Market Cap: $109.24M
P/E (ttm): -2.14
EPS (ttm): -$0.51
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about VIVUS.
CAPS Rating 2 out of 5
 
342 Outperform
65 Underperform
CAPS All Stars
 
48 Outperform
19 Underperform

How do you think VIVUS will perform against the market?



You pick for VIVUS is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Leland F. Wilson, CEO

27% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for VIVUS.

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers